hero section gradient
15 handpicked stocks

State-Owned Champions

Discover a carefully selected portfolio of former government-run enterprises that now trade publicly. These companies combine the market dominance of traditional state monopolies with the growth potential unlocked by private capital, offering a unique balance of stability and opportunity.

Author avatar

Han Tan | Market Analyst

Published on June 18

Your Basket's Financial Footprint

Summary and investor takeaways for the 'State-Owned Champions' basket based on provided market capitalisation breakdown.

Key Takeaways for Investors:
  • Large-cap dominance generally indicates lower volatility and closer tracking of broad-market performance.
  • Suitable as a core holding for long-term allocation rather than a speculative, high-growth position.
  • Expect steady, long-term value appreciation rather than rapid, short-term explosive gains.
Total Market Cap
  • SBS: $16.52B

  • KEP: $19.69B

  • VIV: $19.79B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection targets companies with deep governmental roots that now operate as public corporations in essential sectors. The investment thesis capitalizes on their established market dominance while benefiting from the improved efficiency and growth discipline introduced through privatization and public market accountability.

2

What You Need to Know

These former state monopolies typically command significant market share in foundational industries like utilities, telecommunications, and transportation infrastructure. They often provide essential services to millions, operate in regulated environments, and frequently offer dividend income potential from their steady revenue streams.

3

Why These Stocks

We've identified companies that maintained their strategic importance while successfully transitioning to a public-private structure. Many benefit from infrastructure modernization initiatives and energy transition mandates, creating opportunities for sustained capital investment and growth despite their established market positions.

Why You'll Want to Watch These Stocks

🛡️

Stability With Growth Potential

These former state monopolies offer rare defensive positioning while still capturing upside from infrastructure modernization and energy transition initiatives.

💰

Dividend Income Champions

Many of these companies distribute steady dividends backed by essential services revenue, potentially creating a reliable income stream other investments might miss.

🌎

Global Infrastructure Play

Gain exposure to critical infrastructure assets across multiple countries as governments worldwide funnel capital toward upgrading aging systems and greening their economies.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions